G Medical Innovations Holdings Ltd. Warrants
GMVDW
GMVDW was delisted on the 22nd of August, 2023.
4 hedge funds and large institutions have $152K invested in G Medical Innovations Holdings Ltd. Warrants in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.
740% more capital invested
Capital invested by funds: $18.1K → $152K (+$134K)
0% more funds holding
Funds holding: 4 → 4 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$306 |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$122 |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42 |
GMVDW Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Warrants (GMVDW) for Q3 2022, worth a combined $152K — up 740% from $18.1K a quarter earlier.
Fund positioning in GMVDW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was UBS Group, cutting an estimated $306.
- 4 institutional investors held G Medical Innovations Holdings Ltd. Warrants (GMVDW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $152K of G Medical Innovations Holdings Ltd. Warrants stock for Q3 2022, up 740% quarter-over-quarter.
- 0 funds opened new G Medical Innovations Holdings Ltd. Warrants positions in Q3 2022 and 0 closed out.
- The largest G Medical Innovations Holdings Ltd. Warrants seller in Q3 2022 was UBS Group, an estimated $306 sold.
Based on aggregated 13F filings for Q3 2022.